High-dose rate intraluminal brachytherapy: An effective palliation for cholangiocarcinoma causing bile duct obstruction. (December 2018)

• Record Type: Journal Article
• Authors: Nguyen, Nhu-Tram A.; Timotin, Emilia; Hunter, Robert; Sur, Ranjan K.
• Is Part Of: Surgical oncology. Volume 27:Number 4(2018)
• Page Start: 625
• Page End: 629
• Publication Date: 2018-12
• Subjects: Brachytherapy -- Cholangiocarcinoma -- Bile duct obstruction; Cancer -- Surgery -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Electronic journals; 616.994059
• DOI: 10.1016/j.suronc.2018.07.004
• Languages: English
• ISSNs: 0960-7404

Abstract

Highlights: Intraluminal brachytherapy (ILBT) decreases the need for biliary drain changes. Post-ILBT, the median number of drain changes was 0 (range 0–4). Post ILBT, the 30-day and 60-day patency rates were 88% and 83% respectively. Most patients had a biochemical response; many had their bilirubin normalized.